GSK and Roche increase flu treatment production
This article was originally published in Scrip
Executive Summary
GlaxoSmithKline and Roche are both increasing the production of their antivirals Relenza (zanamivir) and Tamiflu (oseltamivir) respectively in response to the swine flu outbreaks.